GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,534.00
Bid: 12,532.00
Ask: 12,536.00
Change: -56.00 (-0.44%)
Spread: 4.00 (0.032%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-S.Korea signs new Pfizer vaccine deal; asks people to cut travel

Fri, 13th Aug 2021 09:07

(Recasts with Pfizer vaccine deal)

By Sangmi Cha

SEOUL, Aug 13 (Reuters) - South Korea on Friday signed a
deal to buy 30 million doses of Pfizer's COVID-19
vaccine for 2022, and the government urged people to cut holiday
travel amid a worsening fourth wave of infections and a slow
inoculation campaign.

Prime Minister Kim Boo-kyum asked companies to be flexible
about allowing people to work from home and urged those
returning from holiday to get tested, especially before clocking
in for work.

The government's efforts to curb fresh cases have been
stymied by the spread of the highly transmissible Delta variant,
which has made contact tracing hard in the peak summer travel
season. Supply bottlenecks at vaccine maker Moderna
have added to its problems.

South Korea has secured a total of 193 million doses of
vaccines, including from Pfizer, Moderna, AstraZeneca,
Johnson & Johnson and Novavax. It has fully
vaccinated 17.4% of its 52 million population.

Under an existing contract with Pfizer for 66 million doses
this year, the country has received 17.88 million.

Korea Disease Control and Prevention Agency (KDCA) Director
Jeong Eun-kyeong told a briefing on Friday that the doses under
the new Pfizer contract would start to arrive in the first
quarter of 2022, and South Korea had the option to buy another
30 million doses.

Separately, on Friday morning, a government delegation left
for Boston for talks with Moderna over the U.S. vaccine maker's
repeated shipment delays, health ministry official Son Young-rae
told a briefing.

Moderna told Seoul on Monday it would only be able to
deliver less than half the 8.5 million doses it was due to ship
this month. The country has a contract for 40 million doses from
Moderna, and has received around 2.5 million so far.

The KDCA reported 1,990 new COVID-19 infections for
Thursday, after a record daily count of 2,223 on Wednesday https://www.reuters.com/world/asia-pacific/south-koreas-daily-covid-19-cases-hit-record-surpassing-2200-health-minister-2021-08-10.

Total cases stand at 220,182, with 2,144 deaths, and the
government has said the current wave of infections has not
peaked yet.

Kim said the government would secure at least 5% of hospital
beds for serious COVID-19 cases in 26 general hospitals in the
capital Seoul and surrounding areas.

"There have been many workplace clusters recently," Kim told
a televised speech. "Please make sure the employees returning to
work to check for symptoms like fever."

Under the current distancing rules, employers are advised to
increase flexible staffing, with 30% of staff working remotely https://www.reuters.com/world/asia-pacific/south-korea-raise-covid-19-curbs-highest-level-seoul-says-pm-2021-07-08.

(Reporting by Sangmi Cha Editing by Sayantani Ghosh and Mark
Potter)

More News
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.